Filing Details
- Accession Number:
- 0001408408-17-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-27 15:39:57
- Reporting Period:
- 2017-02-23
- Filing Date:
- 2017-02-27
- Accepted Time:
- 2017-02-27 15:39:57
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1331271 | Bryan Kenneth Dart | P. O. Box 31300 Grand Cayman E9 KY1-1206 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock | Acquisiton | 2017-02-23 | 1 | $0.00 | 1 | No | 4 | P | Indirect | By Company |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Company |
Footnotes
- On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.
Billionaire Hedge Funds
